ARCHIVES

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

Gavel Changes Hands At NCAB, Korn advises New Members On Role

February 8, 1991

Reagan Goes On Record Against Smoking, Dietary Fat

April 22, 1988

In Brief: ACS Estimates 502,000 U.S. Cancer Deaths, 178,000 Avoidable With Early Diagnosis

March 17, 1989

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

April 24, 2009

For Frederick, Unseat Program Resources Inc.

March 3, 1995

Agents Not Indicated In Curative Setting.

August 8, 2008